HRS-1893 - Jiangsu Hengrui Pharma
A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy (clinicaltrials.gov) - Sep 11, 2025 - P2 | N=300 | Recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Not yet recruiting ➔ Recruiting 
Enrollment open • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy
http://clinicaltrials.gov/ct2/show/NCT07021963
 
Sep 11, 2025
 
Prev Next